B
Biofrontera D
D
BFRI
0.70210
USD
-0.16
(-18.12%)
قبل الجلسة
حجم التداول
800
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
3,892,104
المقالات
العنوان: Biofrontera
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.